Skip to mainSkip to footer
Alternative strategies

Carmignac Portfolio Merger Arbitrage Plus

Share Class

LU2601233948

Alternative strategiesCarmignac Portfolio Merger Arbitrage Plus
Alternative strategiesCarmignac Portfolio Merger Arbitrage Plus
Share Class

LU2601233948

Overview

Characteristics & Risks

Performance

Portfolio

ESG

Documents

Carmignac Portfolio Merger Arbitrage Plus : Characteristics & Risks

You may find in this section information on characteristics, costs, and risks of the Fund. ​If you have any questions, please do not hesitate to contact Carmignac for further details and assistance.​

Investment Universe and Objective

Carmignac Portfolio Merger Arbitrage Plus is a UCITS Fund, following an alternative investment strategy that seeks to benefit from the price discontinuities (“arbitrage”) of the shares related to merger and acquisition transactions. The Fund invests in officially announced M&A deals in the developed markets. The Fund seeks to achieve a positive absolute return over a 3-year investment horizon through capital growth.

Characteristics

General Characteristics
Management Company
Carmignac Gestion Luxembourg S.A
Legal Form
Luxembourg SICAV sub-fund
ISIN
LU2601233948
Bloomberg
CAPMAFU LX
Detailed Characteristics
SFDR - Fund Classification
Article 8
Risk Indicator

1

2

3

4

5

6

7

Lowest risk Highest risk
Recommended minimum investment horizon
3 years
Management
Alternative strategies
Reference Indicator
-
Morningstar Category
Morningstar Category
Alt - Event Driven
Net Asset Value & Assets Under Management
Date of 1st NAV
14/04/2023
Base Currency
USD
Share class AUM
54 248.67$ (19/12/24)
Fund AUM
148 M€ / 154 M$
Dividend Policy
Accumulation
Capital Guarantee
No
NAV Frequency
Daily, except on French public holidays for FCP/SICAV; UK bank holidays for OEIC; Stock market holidays in the US, China and Hong Kong for China New Economy Funds. 
Subscribe to NAVs
Order Placement Cut-Off Time
Before 13:30 CET

Fees

One-off costs upon entry or exit
Entry costs
We do not charge an entry fee. 
Exit costs
We do not charge an exit fee for this product.
Ongoing costs taken each year
Management fees and other administrative or operating costs
1,25% of the value of your investment per year. This estimate is based on actual costs over the past year.
Transaction Cost
0,98% of the value of your investment per year. This is an estimate of the costs incurred when we buy and sell the investments underlying the product. The actual amount varies depending on the quantity we buy and sell.
Incidental costs taken under specific conditions
Performance fees
20,00% max. of the outperformance if the performance is positive and the net asset value exceeds the high-water mark. The actual amount will vary depending on how well your investment performs. The aggregated cost estimation above includes the average over the last 5 years, or since the product creation if it is less than 5 years.

Risks

Main Risks of the Fund
Equity
The Fund may be affected by stock price variations, the scale of which is dependent on external factors, stock trading volumes or market capitalization.
Arbitrage
Arbitrage seeks to benefit from such price differences (e.g. in markets, sectors, securities, currencies). If arbitrage performs unfavorably, an investment may lose its value and generate a loss for the Sub-Fund.
Risk associated with the Long/Short Strategy
This risk is linked to long and/or short positions designed to adjust net market exposure. The Fund may suffer high losses if its long and short positions undergo simultaneous unfavourable development in opposite directions.
Liquidity
Temporary market distortions may have an impact on the pricing conditions under which the Fund might be caused to liquidate, initiate or modify its positions.
The Fund presents a risk of loss of capital.

Related articles

Alternative Strategy • 18 March 2024 • English

Our Merger Arbitrage strategies win ‘Best new launch’ award

1 minute(s) read
Find out more
All analysis
View overviewView Performance
Reference to certain securities and financial instruments is for illustrative purposes to highlight stocks that are or have been included in the portfolios of funds in the Carmignac range. This is not intended to promote direct investment in those instruments, nor does it constitute investment advice. The Management Company is not subject to prohibition on trading in these instruments prior to issuing any communication. The portfolios of Carmignac funds may change without previous notice.
The reference to a ranking or prize, is no guarantee of the future results of the UCIS or the manager.
Carmignac Portfolio is a sub-fund of Carmignac Portfolio SICAV, an investment company under Luxembourg law, conforming to the UCITS Directive.
The information presented above is not contractually binding and does not constitute investment advice. Past performance is not a reliable indicator of future performance. Performances are net of fees (excluding possible entrance fees charged by the distributor), where applicable. Investors may lose some or all of their capital, as the capital in the UCI is not guaranteed. Access to the products and services presented herein may be restricted for some individuals or countries. Taxation depends on the situation of the individual. The risks, fees and recommended investment period for the UCI presented are detailed in the KIDs (key information documents) and prospectuses available on this website. The KID must be made available to the subscriber prior to purchase.). The reference to a ranking or prize, is no guarantee of the future results of the UCITS or the manager.